DOLUTEGRAVIR/LAMIVUDINE/TENOFOVIR 50 mg + 300 mg + 300 mg Comprimé
AMM_2021_11448
Id:
1095
Presentation:
Boîte de 30
Cis_EQ:
Cis:
Code_ATC:
J05AR27
Dci:
DOLUTEGRAVIR + LAMIVUDINE + TENOFOVIR
Remarque:
Titulaire:
CIPLA QUALITY CHEMICAL INDUSTRIES LTD
Pays:
Inde
Date_fin_AMM:
2027-07-31